No abstract available
MeSH terms
-
Adult
-
Aged
-
Aged, 80 and over
-
Algorithms
-
Anticoagulants / administration & dosage
-
Anticoagulants / adverse effects*
-
Anticoagulants / therapeutic use
-
Blood Coagulation Tests
-
Blood Proteins / analysis
-
COVID-19 / blood*
-
COVID-19 / complications
-
COVID-19 / therapy
-
Clinical Protocols
-
Critical Care
-
Drug Monitoring / methods*
-
Enoxaparin / administration & dosage
-
Enoxaparin / adverse effects*
-
Enoxaparin / therapeutic use
-
Female
-
Hemorrhage / chemically induced
-
Hemorrhage / prevention & control*
-
Heparin / administration & dosage
-
Heparin / adverse effects*
-
Heparin / therapeutic use
-
Humans
-
Male
-
Middle Aged
-
Point-of-Care Testing
-
Postoperative Complications / epidemiology
-
Prospective Studies
-
Respiration, Artificial
-
Risk Factors
-
SARS-CoV-2*
-
Thrombelastography*
-
Thrombophilia / drug therapy*
-
Thrombophilia / etiology
Substances
-
Anticoagulants
-
Blood Proteins
-
Enoxaparin
-
Heparin